Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Enable Therapeutics LLC
Profile last edited on: 2/6/22      CAGE: 8NFR0      UEI: H2HNJZH9VWT8

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2020
First Award
2021
Latest Award
2021
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

68 Donna Road
Framingham, MA 01701
   (508) 844-3985
   N/A
   N/A
Location: Single
Congr. District: 05
County: Middlesex

Public Profile

Enable Therapeutics is a biotechnology company developing an antibody-based drug delivery platform capable of delivering full-length proteins. The platform has applications for neurological and neuromuscular disorders and functions by delivering the protein or oligonucleotide to the cytoplasm of cells that express the ENT2 transporter.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$701,056
Phase II Dollars
$0
Total Awarded
$701,056

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2021 1 NIH $450,022
Project Title: VAL-0914 Decreases PAO to Protect Against Cardiac Proteinopathies
2021 1 NSF $251,034
Project Title: Antibody-Enzyme Fusion for the Treatment of Myotubular Myopathy

Key People / Management

  Robert Shaffer -- Founder / CEO

Company News

There are no news available.